December S&P 500 E-Mini futures (ESZ25) are trending up +0.02% this morning, struggling to regain their footing after a tech-led selloff in the prior session as sentiment remains fragile.
Charles River Laboratories has continued to underperform the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.
Williams-Sonoma has continued to underperform the broader market over the past year, yet analysts remain moderately bullish on the stock’s prospects.
West Pharmaceutical Services has substantially underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects, with price targets suggesting significant upside...
Disney has increased its 2026 dividend by 50% and the payout has risen 1.5X since 2023. Is DIS stock a buy for the dividend hike?
This rare earth stock may be approaching a bottom and setting up for another rally as Wall Street analysts cozy up to its narrative.
MP Materials stock has nearly tripled shareholder returns in 2025 and continues to attract investments from billionaires such as Gina Rinehart.
Wall Street is not buying into the bubble talk. Neither should you.
Fannie Mae stock is gaining momentum on the OTC markets even as its IPO plans might be delayed to 2026.
Exact Sciences stock rallies as Abbott announces a $21 billion deal to acquire to the molecular diagnostics firm. Here’s why EXAS shares are unlikely to push any higher in 2026.
